menu
    • menu

    Company profile for Lannett Company, Inc.

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lannett Company, Inc. manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Our portfolio consists of numerous products across a wide range of therapeutic areas. We believe that our ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically inte...
    Lannett Company, Inc. manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Our portfolio consists of numerous products across a wide range of therapeutic areas. We believe that our ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate ourselves into certain specialty markets and achieve economies in production are all critical for our success in the generic pharmaceutical industry in which we operate. Employing our manufacturing expertise, low overhead expenses and efficient product development, manufacturing and marketing capabilities will help us remain competitive in the general pharmaceutical market. We continue to dedicate significant capital toward developing new products as we believe our success is linked to our ability to continually introduce new generic products into the marketplace. Having cultivated strong and dependable customer relationships by maintaining adequate inventory levels and demonstrating a responsive order filling system, we take pride in our ability to satisfy our customers needs. In doing so, a majority of our orders are filled and shipped either on the day of, or the day following, the date that we receive the order. Our manufacturing facility consists of 31,000 square feet on an approximately 3.5-acre parcel of land that we own. We also own a 63,000 square foot building on approximately 3.0 acres located within one mile of our manufacturing facility that houses packaging, R&D and certain administrative functions. In addition, we recently purchased a third building located several miles from our manufacturing facility, consisting of 66,000 square feet on approximately 7.3 acres. This building will be used as our main distribution facility as well as housing key administrative functional areas supporting the organization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lannett Company, Inc.United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Lannett Company, Inc.13200 Townsend Road Philadelphia, PA 19154
    Telephone
    Telephone
    (215) 333-9000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lannett.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of October 29, 2025
    Enforcement Report - Week of October 29, 2025

    29 Oct 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-29-2025-82388.pdf

    FDA
    29 Oct 2025
    Share Share
    Enforcement Report - Week of September 17, 2025
    Enforcement Report - Week of September 17, 2025

    17 Sep 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-17-2025-5582.pdf

    FDA
    17 Sep 2025
    Share Share
    Enforcement Report - Week of September 3, 2025
    Enforcement Report - Week of September 3, 2025

    03 Sep 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-3-2025-81425.pdf

    FDA
    03 Sep 2025
    Share Share
    Aurobindo to Acquire Lannett Company for Rs. 2,185 Cr
    Aurobindo to Acquire Lannett Company for Rs. 2,185 Cr

    01 Aug 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/aurobindo-to-acquire-lannett-company-for-rs-2185-cr-17515

    INDPHARMAPOST
    01 Aug 2025
    Share Share
    Enforcement Report - Week of December 11, 2024
    Enforcement Report - Week of December 11, 2024

    11 Dec 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-11-2024-90405.pdf

    FDA
    11 Dec 2024
    Share Share
    Lannett Successfully Emerges From Chapter 11 in Stronger Financial Position
    Lannett Successfully Emerges From Chapter 11 in Stronger Financial Position

    16 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230616547789/en

    BUSINESSWIRE
    16 Jun 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Lannett Company, Inc. and get a quotation

    Lannett Company, Inc. is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by Lannett Company, Inc.

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search